Selective PDE4 inhibition is achieved by 4-(substituted-phenyl)-2-pyrrolid- inone compounds. The compounds exhibit improved PDE4 inhibition as compared to compounds like rolipram and show selectivity with regard to inhibition of other classes of PDEs. The compounds of the present invention are of formula I: 1 wherein R.sup.1, R.sup.2, and R.sup.3 are as defined herein.

 
Web www.patentalert.com

< Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides

< Fused Heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

> Methods for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women

> Collective brain measurement system and method

~ 00225